The Abramson Cancer Center of the University of Pennsylvania?
Last Modified: January 6, 2011
Dates: May 13, 2011, 8am - 3pm
Location: Hilton Hotel, 4200 City Avenue, Philadelphia, PA
Sponsoring Group: Abramson Cancer Center
Topics Covered: HOLD THE DATE The 8th Annual Focus on Melanoma Conference is a full day symposium designed to address the personal and medical issues facing those at risk for melanoma, survivors of melanoma, their loved ones, and caregivers. This year's program will include a general session addressing those who are: at risk, newly diagnosed, in treatment, and long term survivors. With an emphasis on promising clinical trials, information on the latest clinical advancements and research findings will be presented for melanoma genetics, proton therapy and its application to melanoma and personalized medicine approaches to treating melanoma.
Agenda: The Abramson Cancer Center and its prominent Melanoma Program are uniquely qualified to present this conference. Penn's Melanoma/Pigmented Lesion Group was founded in the early 1970s by Wallace H. Clark, Jr., MD a premier expert in melanoma research and treatment. Dr Clarke was the first to identify the progressive stages from a mole to early melanoma, making it possible to detect melanoma at a stage when it can be cured. Through this group's work at Penn and the adjacent Wistar Institute, we better understand risk factors for melanoma and of melanoma spreading. The knowledge gained through our research allows us to better treat people with an elevated risk of melanoma and those who have the disease itself.
Penn's outstanding Melanoma Program is comprised of: a nationally recognized team of doctors who have worked together for years caring for patients who have melanoma or are at risk, as well as, expert diagnosticians whose skills are needed to precisely diagnose melanoma. Our team provides individualized attention and care plans tailored to each person's situation. Our strong focus on education and monitoring ensures that melanoma can be prevented or caught early. We place an emphasis on the family, since melanoma risk can be high among family members, and our innovative treatments and clinical trials are unavailable at most hospitals or cancer centers.
Registration Information: Phone and online registration will open as the event nears. For more information, contact Barbara Lopez at email@example.com.
Nov 23, 2014 - Cancer drugs currently under development were the focus of a press briefing held on Nov. 16 at the American Association for Cancer Research -- National Cancer Institute -- European Organisation for Research and Treatment of Cancer International Conference, "Molecular Targets and Cancer Therapeutics," held from Nov. 15 to 19 in Boston.
Nov 23, 2014
Jun 23, 2011
Oct 25, 2013
Nov 11, 2010
Oct 26, 2011